Abbott reduces board size from 13 to 12 directors effective April 24, 2026

ABBOTT LABORATORIES

Board of Directors amended Article III, Section 2 of By-Laws on February 20, 2026.
Board size reduced from 13 to 12 persons, effective April 24, 2026.
Amended By-Laws filed as Exhibit 3.1 to the Form 8-K.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ABBOTT LABORATORIES: Board reduced from thirteen to twelve members, effective April 24, 2026 (effective 2026-04-24).

Change: bylaw amendment
Effective: 2026-04-24

Exact text from the filing

On February 20, 2026, Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s By-Laws to provide that Abbott’s Board of Directors shall consist of twelve persons, effective April 24, 2026.

View on SEC.gov

40 governance changes filed in the last 30 days. Browse all governance changes →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001104659-26-018167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.